Related Experiment Video
Updated: Aug 1, 2025
08:37
Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
866
The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
Ana Beatriz Sousa1,2,3, Judite N Barbosa1,2,3
1i3S-Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-125 Porto, Portugal.
Journal of Functional Biomaterials
|April 27, 2023
Summary
Biomaterials trigger inflammation, but specialized pro-resolving mediators (SPMs) actively resolve it. This review explores using SPMs to engineer advanced immunomodulatory biomaterials for better healing.
Area of Science:
- Biomaterials Science
- Immunology
- Regenerative Medicine
Background:
- Biomaterial implantation initiates an acute inflammatory response crucial for tissue repair.
- Failure to resolve inflammation can lead to chronic responses, impairing healing.
- Specialized pro-resolving mediators (SPMs) actively regulate and terminate inflammatory processes.
Purpose of the Study:
- To review the role of SPMs in resolving inflammation.
- To explore the potential of SPMs in developing novel immunomodulatory biomaterials.
- To provide insights for future research in SPM-based biomaterial engineering.
Main Methods:
- Literature review on inflammation resolution and SPMs.
- Analysis of SPM functions (e.g., reducing PMN recruitment, promoting efferocytosis).
- Discussion of biomaterial strategies for immune modulation.
Main Results:
- SPMs, including lipoxins, resolvins, protectins, and maresins, actively resolve inflammation.
- SPMs exhibit anti-inflammatory and pro-resolutive actions.
- Immunomodulatory biomaterials aim to guide host immune responses for regeneration.
Conclusions:
- SPMs offer a promising avenue for designing biomaterials that actively promote tissue regeneration.
- Engineering biomaterials to incorporate or mimic SPM functions can enhance healing outcomes.
- Future research should focus on translating SPM-based strategies into clinical applications.
Related Concept Videos
01:28Inflammatory Response
2.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.3K
01:24T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
210
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
210
01:29Inflammatory Bowel Disease IV: Pharmacological Management
161
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
161
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
01:40Cell-mediated Immune Responses
69.3K
Overview
69.3K